Volume 25, Issue 4 (In Press_ Winter 2021 2021)                   2021, 25(4): 3-3 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Yekefallah L, Namdar P, Mouri S, Mohammadi S. Identifying the effective factors in the death of patients receiving convalescent plasma. Journal of Inflammatory Diseases. 2021; 25 (4) :3-3
URL: http://journal.qums.ac.ir/article-1-3252-en.html
1- Department of Intensive Care Nursing, Alborz University of Medical Sciences, Karaj, Iran , sareh_mohammadi@ymail.com
Abstract:   (95 Views)
Background: Despite the wild spread of COVID-19 around the world, unfortunately, no definitive treatment has been found for the disease yet.  A wide range of drugs have been tried to reduce the mortality rate. Convalescent plasma injection is considered a beneficial method to control the illness.
Objective: The aim of this study is to determine the outcomes of patients receiving this therapy in Qazvin Bu-Ali hospital.
Methods: The present study is a case series of 60 samples. The samples were selected by purposive method, and the survey was only conducted after an ethics license and patients’ consent had been obtained in 2020. The inclusion criteria into the population were having a lung scan confirmed by an internist or infectious disease specialist, a positive PCR test, and a history of receiving plasma during treatment.
Results: Out of 60 patients with COVID-19 who received convalescent plasma, 33 (55%) patients survived. The findings indicate that patients who received plasma and died were not significantly different from surviving patients in terms of age, sex, underlying disease, and length of hospital stay (P>0.05). There was a significant difference between the deceased and surviving patients in terms of plasma receiving time (P=0.005).
Conclusion: Convalescent plasma injection of patients represented that the closer to the time of admission, the greater the effect on reducing patient mortality.
Type of Study: Research | Subject: Infectious Disease

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb